View in EDS HTML Full Text PDF Full Text

Safety and efficacy of temsirolimus in combination with three different immuno-chemotherapy regimens in relapse and refractory mantle cell lymphoma, final results of the T3 phase IB trial of the LYSA.

Saved in:
Bibliographic Details
Title: Safety and efficacy of temsirolimus in combination with three different immuno-chemotherapy regimens in relapse and refractory mantle cell lymphoma, final results of the T3 phase IB trial of the LYSA.
Authors: Tessoulin, Benoît1,2 (AUTHOR), Bouabdallah, Kamal3 (AUTHOR), Burroni, Barbara4 (AUTHOR), Lamy, Thierry5 (AUTHOR), Gressin, Remy6 (AUTHOR), Cartron, Guillaume7 (AUTHOR), Thieblemont, Catherine8 (AUTHOR), Sarkozy, Clémentine9 (AUTHOR), Haioun, Corinne10 (AUTHOR), Casasnovas, Olivier11 (AUTHOR), Joubert, Clementine12 (AUTHOR), Gyan, Emmanuel13 (AUTHOR), Hermine, Olivier14 (AUTHOR), Le Gouill, Steven1,2,15 (AUTHOR) steven.legouill@chu-nantes.fr
Source: Annals of Hematology. Aug2020, Vol. 99 Issue 8, p1771-1778. 8p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 144422883
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Safety and efficacy of temsirolimus in combination with three different immuno-chemotherapy regimens in relapse and refractory mantle cell lymphoma, final results of the T<superscript>3</superscript> phase IB trial of the LYSA.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Tessoulin%2C+Benoît%22">Tessoulin, Benoît</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bouabdallah%2C+Kamal%22">Bouabdallah, Kamal</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Burroni%2C+Barbara%22">Burroni, Barbara</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lamy%2C+Thierry%22">Lamy, Thierry</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gressin%2C+Remy%22">Gressin, Remy</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cartron%2C+Guillaume%22">Cartron, Guillaume</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Thieblemont%2C+Catherine%22">Thieblemont, Catherine</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sarkozy%2C+Clémentine%22">Sarkozy, Clémentine</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Haioun%2C+Corinne%22">Haioun, Corinne</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Casasnovas%2C+Olivier%22">Casasnovas, Olivier</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Joubert%2C+Clementine%22">Joubert, Clementine</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gyan%2C+Emmanuel%22">Gyan, Emmanuel</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hermine%2C+Olivier%22">Hermine, Olivier</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Le+Gouill%2C+Steven%22">Le Gouill, Steven</searchLink><relatesTo>1,2,15</relatesTo> (AUTHOR)<i> steven.legouill@chu-nantes.fr</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Hematology%22">Annals of Hematology</searchLink>. Aug2020, Vol. 99 Issue 8, p1771-1778. 8p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=144422883
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00277-020-04159-3
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 8
        StartPage: 1771
    Titles:
      – TitleFull: Safety and efficacy of temsirolimus in combination with three different immuno-chemotherapy regimens in relapse and refractory mantle cell lymphoma, final results of the T3 phase IB trial of the LYSA.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Tessoulin, Benoît
      – PersonEntity:
          Name:
            NameFull: Bouabdallah, Kamal
      – PersonEntity:
          Name:
            NameFull: Burroni, Barbara
      – PersonEntity:
          Name:
            NameFull: Lamy, Thierry
      – PersonEntity:
          Name:
            NameFull: Gressin, Remy
      – PersonEntity:
          Name:
            NameFull: Cartron, Guillaume
      – PersonEntity:
          Name:
            NameFull: Thieblemont, Catherine
      – PersonEntity:
          Name:
            NameFull: Sarkozy, Clémentine
      – PersonEntity:
          Name:
            NameFull: Haioun, Corinne
      – PersonEntity:
          Name:
            NameFull: Casasnovas, Olivier
      – PersonEntity:
          Name:
            NameFull: Joubert, Clementine
      – PersonEntity:
          Name:
            NameFull: Gyan, Emmanuel
      – PersonEntity:
          Name:
            NameFull: Hermine, Olivier
      – PersonEntity:
          Name:
            NameFull: Le Gouill, Steven
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: Aug2020
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-print
              Value: 09395555
          Numbering:
            – Type: volume
              Value: 99
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Annals of Hematology
              Type: main
ResultId 1